Pediatric HIV/AIDS and the skin: an update

Gavin M Gottschalk1

  • 1Division of Dermatology, Red Cross Children's Hospital and the University of Cape Town, Klipfontein Road, Rondebosch, Cape Town, 7700, South Africa. gavgott@ich.uct.ac.za

Dermatologic Clinics
|October 3, 2006
PubMed

Insights

Pediatric HIV/AIDS in sub-Saharan Africa affects millions, with skin conditions being common. This review covers epidemiology, skin disease as an immune indicator, immune reconstitution inflammatory syndrome, and antiretroviral impacts.

Area of Science:

  • Pediatric infectious diseases
  • Dermatology
  • Immunology

Background:

  • Sub-Saharan Africa had 2.1 million children under 15 living with HIV in 2005.
  • Skin diseases are a common co-morbidity in pediatric HIV/AIDS, mirroring adult trends.

Purpose of the Study:

  • To provide an updated overview of pediatric HIV/AIDS and its dermatological manifestations.
  • To examine skin conditions as indicators of immune status in children with HIV.
  • To discuss immune reconstitution inflammatory syndrome (IRIS) and the effects of antiretroviral therapy (ART) on skin disease.

Main Methods:

  • Literature review and synthesis of current data on pediatric HIV/AIDS.
  • Analysis of epidemiological trends in sub-Saharan Africa.
  • Review of the relationship between skin manifestations and immune status, IRIS, and ART.

Main Results:

  • Skin diseases are highly prevalent in children with HIV/AIDS.
  • Cutaneous manifestations can serve as valuable indicators of a child's immune status.
  • IRIS and ART significantly influence the spectrum and management of skin conditions.

Conclusions:

  • Understanding the epidemiology and dermatological aspects of pediatric HIV/AIDS is crucial for effective management.
  • Skin health monitoring is essential for assessing immune function and treatment response in HIV-infected children.
  • Further research is needed to optimize the management of skin diseases in the context of evolving HIV/AIDS treatment.

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Retrovirus Life Cycles01:10

Retrovirus Life Cycles

Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the retrovirus to...
Sexually Transmitted Infections01:26

Sexually Transmitted Infections

Sexually transmitted infections (STIs) are diseases transmitted primarily through unsafe sexual interactions. Bacteria, viruses, or parasites cause them and can result in severe health complications if untreated.ChlamydiaThe bacterium Chlamydia trachomatis is responsible for the disease Chlamydia, the most common STI in the United States. This peculiar pathogen requires human cells to reproduce, residing intracellularly. The initial infection often goes unnoticed because it typically does not...
Immunodeficiency Diseases01:25

Immunodeficiency Diseases

Immunodeficiency disorders are conditions in which the immune system's ability to fight infectious disease and cancer is compromised or entirely absent. The immune system comprises a complex network of cells, tissues, and organs that work together to protect the body from potentially harmful invaders. When this system is deficient or not functioning properly, it leaves the body susceptible to infections, diseases, or other complications.
There are three main causes of immunodeficiency disorders...
Changes in Skin Color: Clinical Perspectives01:14

Changes in Skin Color: Clinical Perspectives

The first thing a clinician sees is the skin, so the examination of the skin should be part of any thorough physical examination. Most skin disorders are relatively benign, but a few, including melanomas, can be fatal if untreated. A couple of the more noticeable disorders, albinism and vitiligo, affect the appearance of the skin and its accessory organs.
Albinism
Albinism is a genetic disorder that affects (completely or partially) the coloring of skin, hair, and eyes. The defect is primarily...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...